SWM
LABU icon

SeaCrest Wealth Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

SeaCrest Wealth Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-13
Closed -$8K – 2189
2018
Q4 		$8K Buy
+13
New +$13.6K ﹤0.01% 1553

Other funds holding LABU

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

SeaCrest Wealth Management's LABU Position: Q1 2019 in Review

SeaCrest Wealth Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2019, closing a stake of 13 shares — an estimated $8K sold.

SeaCrest Wealth Management first reported a position in LABU in Q4 2018 and held it in 1 quarter. The position peaked at $8K in Q4 2018. 23 funds tracked by Wall St. Rank hold LABU as of Q1 2019.

  • SeaCrest Wealth Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2019 after selling out during the quarter.
  • SeaCrest Wealth Management sold 13 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2019, an estimated $8K.
  • SeaCrest Wealth Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2018 and held it in 1 quarter.
  • SeaCrest Wealth Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $8K in Q4 2018.
  • 23 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2019.

Based on SeaCrest Wealth Management's 13F filing for Q1 2019, filed 10 May 2019.